HomeQTTB • NASDAQ
Q32 Bio Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.98M | 41.77% |
Net income | -14.19M | 47.58% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -14.41M | 43.91% |
Effective tax rate | 10.16% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 77.97M | 204.35% |
Total assets | 92.33M | 96.21% |
Total liabilities | 86.66M | -26.89% |
Total equity | 5.68M | — |
Shares outstanding | 12.20M | — |
Price to book | 3.16 | — |
Return on assets | -36.89% | — |
Return on capital | -111.78% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -14.19M | 47.58% |
Cash from operations | -11.43M | -6.65% |
Cash from investing | -2.00K | — |
Cash from financing | 317.00K | 317.11% |
Net change in cash | -11.11M | -4.46% |
Free cash flow | -3.51M | 90.69% |
Previous close
$1.49
Day range
$1.40 - $1.62
Year range
$1.40 - $53.73
Market cap
19.55M USD
Avg Volume
175.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
43
